Inhibition of Hsp90 acts synergistically with topoisomerase II poisons to increase the apoptotic killing of cells due to an increase in topoisomerase II mediated DNA damage
Topoisomerase II plays a crucial role during chromosome condensation and segregation in mitosis and meiosis and is a highly attractive target for chemotherapeutic agents. We have identified previously topoisomerase II and heat shock protein 90 (Hsp90) as part of a complex. In this paper we demonstra...
Gespeichert in:
Veröffentlicht in: | Nucleic acids research 2006-01, Vol.34 (4), p.1148-1157 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1157 |
---|---|
container_issue | 4 |
container_start_page | 1148 |
container_title | Nucleic acids research |
container_volume | 34 |
creator | Barker, Catherine R. McNamara, Anne V. Rackstraw, Stephen A. Nelson, David E. White, Mike R. Watson, Alastair J. M. Jenkins, John R. |
description | Topoisomerase II plays a crucial role during chromosome condensation and segregation in mitosis and meiosis and is a highly attractive target for chemotherapeutic agents. We have identified previously topoisomerase II and heat shock protein 90 (Hsp90) as part of a complex. In this paper we demonstrate that drug combinations targeting these two enzymes cause a synergistic increase in apoptosis. The objective of our study was to identify the mode of cell killing and the mechanism behind the increase in topoisomerase II mediated DNA damage. Importantly we demonstrate that Hsp90 inhibition results in an increased topoiosmerase II activity but not degradation of topoisomerase II and it is this, in the presence of a topoisomerase II poison that causes the increase in cell death. Our results suggest a novel mechanism of action where the inhibition of Hsp90 disrupts the Hsp90–topoisomerase II interaction leading to an increase in and activation of unbound topoisomerase II, which, in the presence of a topoisomerase II poison leads to the formation of an increased number of cleavable complexes ultimately resulting in rise in DNA damage and a subsequent increase cell death. |
doi_str_mv | 10.1093/nar/gkj516 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1373695</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1034601231</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-49acb248332e07f57ab5ab32076db4e587ec88cfa94be13bb196c5ffe6b74adf3</originalsourceid><addsrcrecordid>eNplkV9v0zAUxSMEYmXwwgdAFo9IYXb8J8kL0jRgrTTBkAaaeLFs5yZ1m9rBdoF-Jz4kLq02EE-WfX733GOdonhO8GuCW3rmVDgb1itOxINiRqioStaK6mExwxTzkmDWnBRPYlxhTBjh7HFxQgTHmWlmxa-FW1ptk_UO-R7N49RipEyKKO4chMHGZI0axx36YdMSJT95G_0GgoqAFgv05-piFpB1JsD-OS0BqclPyedZtLbjaN2wdzcwjhF1W9jjyt1PWPe_8wY6qxJ06O2Hc9SpjRrgafGoV2OEZ8fztPj8_t3Nxby8-ni5uDi_Kg1jJOXfK6Mr1lBaAa57XivNlaYVrkWnGfCmBtM0plct00Co1qQVhvc9CF0z1fX0tHhz8J22Oscw4FJQo5yC3aiwk15Z-a_i7FIO_rsktKai5dng5dEg-G9biEmu_Da4nFlWGAvBBWkz9OoAmeBjDNDfLSBY7ouVuVh5KDbDL_6OdI8em8xAeQByY_DzTldhLUVNay7nt1_l9eUNbm4_Xcsv9Dfsf7Qb</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>200665619</pqid></control><display><type>article</type><title>Inhibition of Hsp90 acts synergistically with topoisomerase II poisons to increase the apoptotic killing of cells due to an increase in topoisomerase II mediated DNA damage</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Oxford Journals Open Access Collection</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Barker, Catherine R. ; McNamara, Anne V. ; Rackstraw, Stephen A. ; Nelson, David E. ; White, Mike R. ; Watson, Alastair J. M. ; Jenkins, John R.</creator><creatorcontrib>Barker, Catherine R. ; McNamara, Anne V. ; Rackstraw, Stephen A. ; Nelson, David E. ; White, Mike R. ; Watson, Alastair J. M. ; Jenkins, John R.</creatorcontrib><description>Topoisomerase II plays a crucial role during chromosome condensation and segregation in mitosis and meiosis and is a highly attractive target for chemotherapeutic agents. We have identified previously topoisomerase II and heat shock protein 90 (Hsp90) as part of a complex. In this paper we demonstrate that drug combinations targeting these two enzymes cause a synergistic increase in apoptosis. The objective of our study was to identify the mode of cell killing and the mechanism behind the increase in topoisomerase II mediated DNA damage. Importantly we demonstrate that Hsp90 inhibition results in an increased topoiosmerase II activity but not degradation of topoisomerase II and it is this, in the presence of a topoisomerase II poison that causes the increase in cell death. Our results suggest a novel mechanism of action where the inhibition of Hsp90 disrupts the Hsp90–topoisomerase II interaction leading to an increase in and activation of unbound topoisomerase II, which, in the presence of a topoisomerase II poison leads to the formation of an increased number of cleavable complexes ultimately resulting in rise in DNA damage and a subsequent increase cell death.</description><identifier>ISSN: 0305-1048</identifier><identifier>EISSN: 1362-4962</identifier><identifier>DOI: 10.1093/nar/gkj516</identifier><identifier>PMID: 16504968</identifier><identifier>CODEN: NARHAD</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Apoptosis ; Benzoquinones ; Cell Line, Tumor ; Checkpoint Kinase 1 ; DNA - metabolism ; DNA Damage ; DNA Topoisomerases, Type II - metabolism ; Drug Synergism ; Enzyme Inhibitors - toxicity ; Etoposide - toxicity ; HSP90 Heat-Shock Proteins - antagonists & inhibitors ; Humans ; Lactams, Macrocyclic ; Protein Kinases - metabolism ; Quinones - toxicity ; Topoisomerase II Inhibitors</subject><ispartof>Nucleic acids research, 2006-01, Vol.34 (4), p.1148-1157</ispartof><rights>Copyright Oxford University Press(England) 2006</rights><rights>The Author 2006. Published by Oxford University Press. All rights reserved 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-49acb248332e07f57ab5ab32076db4e587ec88cfa94be13bb196c5ffe6b74adf3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373695/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373695/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16504968$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barker, Catherine R.</creatorcontrib><creatorcontrib>McNamara, Anne V.</creatorcontrib><creatorcontrib>Rackstraw, Stephen A.</creatorcontrib><creatorcontrib>Nelson, David E.</creatorcontrib><creatorcontrib>White, Mike R.</creatorcontrib><creatorcontrib>Watson, Alastair J. M.</creatorcontrib><creatorcontrib>Jenkins, John R.</creatorcontrib><title>Inhibition of Hsp90 acts synergistically with topoisomerase II poisons to increase the apoptotic killing of cells due to an increase in topoisomerase II mediated DNA damage</title><title>Nucleic acids research</title><addtitle>Nucl. Acids Res</addtitle><description>Topoisomerase II plays a crucial role during chromosome condensation and segregation in mitosis and meiosis and is a highly attractive target for chemotherapeutic agents. We have identified previously topoisomerase II and heat shock protein 90 (Hsp90) as part of a complex. In this paper we demonstrate that drug combinations targeting these two enzymes cause a synergistic increase in apoptosis. The objective of our study was to identify the mode of cell killing and the mechanism behind the increase in topoisomerase II mediated DNA damage. Importantly we demonstrate that Hsp90 inhibition results in an increased topoiosmerase II activity but not degradation of topoisomerase II and it is this, in the presence of a topoisomerase II poison that causes the increase in cell death. Our results suggest a novel mechanism of action where the inhibition of Hsp90 disrupts the Hsp90–topoisomerase II interaction leading to an increase in and activation of unbound topoisomerase II, which, in the presence of a topoisomerase II poison leads to the formation of an increased number of cleavable complexes ultimately resulting in rise in DNA damage and a subsequent increase cell death.</description><subject>Apoptosis</subject><subject>Benzoquinones</subject><subject>Cell Line, Tumor</subject><subject>Checkpoint Kinase 1</subject><subject>DNA - metabolism</subject><subject>DNA Damage</subject><subject>DNA Topoisomerases, Type II - metabolism</subject><subject>Drug Synergism</subject><subject>Enzyme Inhibitors - toxicity</subject><subject>Etoposide - toxicity</subject><subject>HSP90 Heat-Shock Proteins - antagonists & inhibitors</subject><subject>Humans</subject><subject>Lactams, Macrocyclic</subject><subject>Protein Kinases - metabolism</subject><subject>Quinones - toxicity</subject><subject>Topoisomerase II Inhibitors</subject><issn>0305-1048</issn><issn>1362-4962</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkV9v0zAUxSMEYmXwwgdAFo9IYXb8J8kL0jRgrTTBkAaaeLFs5yZ1m9rBdoF-Jz4kLq02EE-WfX733GOdonhO8GuCW3rmVDgb1itOxINiRqioStaK6mExwxTzkmDWnBRPYlxhTBjh7HFxQgTHmWlmxa-FW1ptk_UO-R7N49RipEyKKO4chMHGZI0axx36YdMSJT95G_0GgoqAFgv05-piFpB1JsD-OS0BqclPyedZtLbjaN2wdzcwjhF1W9jjyt1PWPe_8wY6qxJ06O2Hc9SpjRrgafGoV2OEZ8fztPj8_t3Nxby8-ni5uDi_Kg1jJOXfK6Mr1lBaAa57XivNlaYVrkWnGfCmBtM0plct00Co1qQVhvc9CF0z1fX0tHhz8J22Oscw4FJQo5yC3aiwk15Z-a_i7FIO_rsktKai5dng5dEg-G9biEmu_Da4nFlWGAvBBWkz9OoAmeBjDNDfLSBY7ouVuVh5KDbDL_6OdI8em8xAeQByY_DzTldhLUVNay7nt1_l9eUNbm4_Xcsv9Dfsf7Qb</recordid><startdate>20060101</startdate><enddate>20060101</enddate><creator>Barker, Catherine R.</creator><creator>McNamara, Anne V.</creator><creator>Rackstraw, Stephen A.</creator><creator>Nelson, David E.</creator><creator>White, Mike R.</creator><creator>Watson, Alastair J. M.</creator><creator>Jenkins, John R.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7SS</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20060101</creationdate><title>Inhibition of Hsp90 acts synergistically with topoisomerase II poisons to increase the apoptotic killing of cells due to an increase in topoisomerase II mediated DNA damage</title><author>Barker, Catherine R. ; McNamara, Anne V. ; Rackstraw, Stephen A. ; Nelson, David E. ; White, Mike R. ; Watson, Alastair J. M. ; Jenkins, John R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-49acb248332e07f57ab5ab32076db4e587ec88cfa94be13bb196c5ffe6b74adf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Apoptosis</topic><topic>Benzoquinones</topic><topic>Cell Line, Tumor</topic><topic>Checkpoint Kinase 1</topic><topic>DNA - metabolism</topic><topic>DNA Damage</topic><topic>DNA Topoisomerases, Type II - metabolism</topic><topic>Drug Synergism</topic><topic>Enzyme Inhibitors - toxicity</topic><topic>Etoposide - toxicity</topic><topic>HSP90 Heat-Shock Proteins - antagonists & inhibitors</topic><topic>Humans</topic><topic>Lactams, Macrocyclic</topic><topic>Protein Kinases - metabolism</topic><topic>Quinones - toxicity</topic><topic>Topoisomerase II Inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barker, Catherine R.</creatorcontrib><creatorcontrib>McNamara, Anne V.</creatorcontrib><creatorcontrib>Rackstraw, Stephen A.</creatorcontrib><creatorcontrib>Nelson, David E.</creatorcontrib><creatorcontrib>White, Mike R.</creatorcontrib><creatorcontrib>Watson, Alastair J. M.</creatorcontrib><creatorcontrib>Jenkins, John R.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Nucleic acids research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barker, Catherine R.</au><au>McNamara, Anne V.</au><au>Rackstraw, Stephen A.</au><au>Nelson, David E.</au><au>White, Mike R.</au><au>Watson, Alastair J. M.</au><au>Jenkins, John R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of Hsp90 acts synergistically with topoisomerase II poisons to increase the apoptotic killing of cells due to an increase in topoisomerase II mediated DNA damage</atitle><jtitle>Nucleic acids research</jtitle><addtitle>Nucl. Acids Res</addtitle><date>2006-01-01</date><risdate>2006</risdate><volume>34</volume><issue>4</issue><spage>1148</spage><epage>1157</epage><pages>1148-1157</pages><issn>0305-1048</issn><eissn>1362-4962</eissn><coden>NARHAD</coden><abstract>Topoisomerase II plays a crucial role during chromosome condensation and segregation in mitosis and meiosis and is a highly attractive target for chemotherapeutic agents. We have identified previously topoisomerase II and heat shock protein 90 (Hsp90) as part of a complex. In this paper we demonstrate that drug combinations targeting these two enzymes cause a synergistic increase in apoptosis. The objective of our study was to identify the mode of cell killing and the mechanism behind the increase in topoisomerase II mediated DNA damage. Importantly we demonstrate that Hsp90 inhibition results in an increased topoiosmerase II activity but not degradation of topoisomerase II and it is this, in the presence of a topoisomerase II poison that causes the increase in cell death. Our results suggest a novel mechanism of action where the inhibition of Hsp90 disrupts the Hsp90–topoisomerase II interaction leading to an increase in and activation of unbound topoisomerase II, which, in the presence of a topoisomerase II poison leads to the formation of an increased number of cleavable complexes ultimately resulting in rise in DNA damage and a subsequent increase cell death.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>16504968</pmid><doi>10.1093/nar/gkj516</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0305-1048 |
ispartof | Nucleic acids research, 2006-01, Vol.34 (4), p.1148-1157 |
issn | 0305-1048 1362-4962 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1373695 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Oxford Journals Open Access Collection; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Apoptosis Benzoquinones Cell Line, Tumor Checkpoint Kinase 1 DNA - metabolism DNA Damage DNA Topoisomerases, Type II - metabolism Drug Synergism Enzyme Inhibitors - toxicity Etoposide - toxicity HSP90 Heat-Shock Proteins - antagonists & inhibitors Humans Lactams, Macrocyclic Protein Kinases - metabolism Quinones - toxicity Topoisomerase II Inhibitors |
title | Inhibition of Hsp90 acts synergistically with topoisomerase II poisons to increase the apoptotic killing of cells due to an increase in topoisomerase II mediated DNA damage |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A32%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20Hsp90%20acts%20synergistically%20with%20topoisomerase%20II%20poisons%20to%20increase%20the%20apoptotic%20killing%20of%20cells%20due%20to%20an%20increase%20in%20topoisomerase%20II%20mediated%20DNA%20damage&rft.jtitle=Nucleic%20acids%20research&rft.au=Barker,%20Catherine%20R.&rft.date=2006-01-01&rft.volume=34&rft.issue=4&rft.spage=1148&rft.epage=1157&rft.pages=1148-1157&rft.issn=0305-1048&rft.eissn=1362-4962&rft.coden=NARHAD&rft_id=info:doi/10.1093/nar/gkj516&rft_dat=%3Cproquest_pubme%3E1034601231%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=200665619&rft_id=info:pmid/16504968&rfr_iscdi=true |